logo
logo
AI Products 

Rapid Tests Market Expected to Reach $97.61 Billion by 2030 | CAGR of 11.3%

avatar
Kanika Gupte
Rapid Tests Market Expected to Reach $97.61 Billion by 2030 | CAGR of 11.3%

According to a new report published by Allied Market Research, titled, Rapid Tests Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030," the global rapid tests market size was valued at $33,329.15 million in 2020, and is projected to reach $97,606.33 million by 2030, registering a CAGR of 11.3% from 2021 to 2030.


Download Free PDF Here -

https://www.alliedmarketresearch.com/request-sample/4633


The increasing incidence of chronic diseases such as diabetes, heart disease, and cancer, increased availability of tests due to the convenience of testing, and low cost of testing are the major factors driving the market growth. quick test. In addition, other factors such as speed of analysis, specificity, and stability are driving the growth of the market worldwide. In addition, the growth in personalized care and the increase in support programs by manufacturers encourage the use of rapid testing, which improves market growth.


However, strict government regulations for the adoption of rapid testing and the recall of many products due to false results are expected to hinder market growth. The coronavirus disease (COVID-19) began in late December 2019 in the Hubei province of Wuhan, China. The virus, the severe respiratory disease coronavirus 2 (SARS-CoV-2) is transmitted among humans. The COVID-19 rapid test kit helps in the diagnosis of the corona virus and thus provides important advice for the subsequent diagnosis, treatment and treatment of COVID-19. The demand for rapid COVID-19 testing has increased with the increase in the number of COVID-19 patients.


Request Customization -

https://www.alliedmarketresearch.com/request-for-customization/4633


Key market players:

  • Akers Biosciences, Inc.
  • Alere Inc. (Abbott Laboratories)
  • Becton, Dickinson and Company
  • Bio-rad Laboratories, Inc.
  • Cepheid, Inc.
  • Hologic, Inc.
  • Meridian Bioscience, Inc.
  • OraSure Technologies, Inc


Key findings of the study:

  • Based on product, the over-the-counter (OTC) rapid test product segment is expected to show the fastest rapid tests market growth, at a CAGR of 11.9% from 2021 to 2030.
  • Based on application, the glucose monitoring segment held maximum global rapid tests market share in 2020 and is expected to remain dominant throughout the forecast period.
  • Based on end user, the hospitals & clinicssegment exhibited growth at a CAGR of 11.8% from 2021 to 2030.
  • Based on region, Asia-Pacific is projected to experience growth at the highest rate, registering a CAGR of 12.8% during the forecast period.


Buy Now -

https://www.alliedmarketresearch.com/checkout-final/ffc622cc2a0f3d53ec13c0c533fa57d2


Contact: David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

[email protected]

Web: https://www.alliedmarketresearch.com

collect
0
avatar
Kanika Gupte
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more